Skip to main content
Erschienen in: Der Nervenarzt 9/2007

01.09.2007 | Kasuistiken

Demenz mit Lewy-Körperchen

Besserung unter Therapie mit einem Acetylcholinesteraseinhibitor

verfasst von: M. Omerovic, S.J. Teipel, T. Hampel

Erschienen in: Der Nervenarzt | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Demenz mit Lewy-Körperchen (Demenz mit Lewy bodies, DLB) stellt die zweihäufigste degenerative Demenzform jenseits des 65. Lebensjahres dar. Klinisch ist die Erkrankung durch ein demenzielles Syndrom, spontane extrapyramidale motorische Symptome (EPMS), Halluzinationen und Fluktuationen der Aufmerksamkeit charakterisiert. Die postulierten klinischen Diagnosekriterien sind vor allem bei der Abgrenzung zu einer Alzheimer-Demenz sehr hilfreich. Bei der DLB liegt ein ausgeprägtes cholinerges Defizit vor, das für eine vielgestaltige Symptomatik mit Demenz und psychotischen Symptomen verantwortlich ist. Wir berichten über einen 83-jährigen, an einer DLB erkrankten Patienten, der sich aufgrund von fluktuierenden Verwirrtheitszuständen und optischen Halluzinationen vorstellte. Nachdem mehrere atypische Neuroleptika keinen Effekt zeigten, erbrachte eine Behandlung mit einem Acetylcholinesteraseinhibitor (Donepezil) eine deutliche Besserung der Kognition und der Verhaltensauffälligkeiten.
Literatur
1.
Zurück zum Zitat Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16: 528–536PubMedCrossRef Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16: 528–536PubMedCrossRef
2.
Zurück zum Zitat Baba M, Nakajo S, Tu PH et al. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152: 879–884PubMed Baba M, Nakajo S, Tu PH et al. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152: 879–884PubMed
3.
Zurück zum Zitat Ballard CG, Aarsland D, McKeith IG et al. (2002) Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 59: 1714–1720PubMed Ballard CG, Aarsland D, McKeith IG et al. (2002) Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 59: 1714–1720PubMed
4.
Zurück zum Zitat Ballard C, Piggott M, Johnson M et al. (2000) Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 48: 868–876PubMedCrossRef Ballard C, Piggott M, Johnson M et al. (2000) Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 48: 868–876PubMedCrossRef
5.
Zurück zum Zitat Cummings JL, Mega M, Gray K et al. (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314PubMed Cummings JL, Mega M, Gray K et al. (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314PubMed
6.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) „Mini-Mental State“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) „Mini-Mental State“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198PubMedCrossRef
7.
Zurück zum Zitat Gnanalingham KK, Byrne EJ,Thornton A et al. (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry 62: 243–252PubMed Gnanalingham KK, Byrne EJ,Thornton A et al. (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry 62: 243–252PubMed
8.
Zurück zum Zitat Heyman A,Fillenbaum GG, Gearing M et al. (1999) Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease. Neurology 52: 1839–1844PubMed Heyman A,Fillenbaum GG, Gearing M et al. (1999) Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease. Neurology 52: 1839–1844PubMed
9.
Zurück zum Zitat Jellinger KA (1999) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 18: 214–215PubMed Jellinger KA (1999) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 18: 214–215PubMed
10.
Zurück zum Zitat Lanctôt KL, Herrmann N (2000) Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 15: 338–345PubMedCrossRef Lanctôt KL, Herrmann N (2000) Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 15: 338–345PubMedCrossRef
11.
Zurück zum Zitat Langlais PJ, Thal L, Hansen L et al. (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 43: 1927–1934PubMed Langlais PJ, Thal L, Hansen L et al. (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 43: 1927–1934PubMed
12.
Zurück zum Zitat Lebert F, Pasquier F, Souliez L et al. (1998) Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 13: 516–519PubMedCrossRef Lebert F, Pasquier F, Souliez L et al. (1998) Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 13: 516–519PubMedCrossRef
13.
Zurück zum Zitat Lewy FH (1912) Paralysis agitans: I. Pathologische Anatomie. In: Lewandowsky M (Hrsg) Handbuch der Neurologie. Vol 3. Springer, Berlin, S 920–933 Lewy FH (1912) Paralysis agitans: I. Pathologische Anatomie. In: Lewandowsky M (Hrsg) Handbuch der Neurologie. Vol 3. Springer, Berlin, S 920–933
14.
Zurück zum Zitat McKeith et al. (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium Neurology 65: 1863 McKeith et al. (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium Neurology 65: 1863
15.
Zurück zum Zitat McKeith IG, Del Ser T, Spano PF et al. (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356: 2031–2036PubMedCrossRef McKeith IG, Del Ser T, Spano PF et al. (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356: 2031–2036PubMedCrossRef
16.
Zurück zum Zitat McKeith IG, Galasko D, Kosaka K et al. (1996) Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113–1124PubMed McKeith IG, Galasko D, Kosaka K et al. (1996) Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113–1124PubMed
17.
Zurück zum Zitat McKeith IG, Perry RH, Fairbairn AF et al. (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22: 911–922PubMedCrossRef McKeith IG, Perry RH, Fairbairn AF et al. (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22: 911–922PubMedCrossRef
18.
Zurück zum Zitat Perry EK, Marshall E, Perry RH et al. (1990) Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 4: 87–96PubMed Perry EK, Marshall E, Perry RH et al. (1990) Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 4: 87–96PubMed
19.
Zurück zum Zitat Perry EK et al. (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson’s disease, and Alzheimer’s disease. Ann N Y Acad Sci 640: 197–202PubMed Perry EK et al. (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson’s disease, and Alzheimer’s disease. Ann N Y Acad Sci 640: 197–202PubMed
20.
Zurück zum Zitat Perry RH, McKeith IG, Perry EK (1996) Introduction. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge Univ Press, Cambridge, pp 1–5 Perry RH, McKeith IG, Perry EK (1996) Introduction. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge Univ Press, Cambridge, pp 1–5
21.
Zurück zum Zitat Querfurth HW, Allam GJ, Geffroy MA et al. (2000) Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord 11: 314–321PubMedCrossRef Querfurth HW, Allam GJ, Geffroy MA et al. (2000) Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord 11: 314–321PubMedCrossRef
22.
Zurück zum Zitat Samuel W, Caligiuri M, Galasko D et al. (2000) Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 15: 794–802PubMedCrossRef Samuel W, Caligiuri M, Galasko D et al. (2000) Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 15: 794–802PubMedCrossRef
23.
Zurück zum Zitat Shea C, MacKnight C, Rockwood K (1998) Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 10: 229–238PubMedCrossRef Shea C, MacKnight C, Rockwood K (1998) Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 10: 229–238PubMedCrossRef
24.
Zurück zum Zitat Shiozaki K, Iseki E, Uchiyama H et al. (1999) Alterations ofmuscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer’s disease. J Neurol Neurosurg Psychiatry 67: 209–213PubMedCrossRef Shiozaki K, Iseki E, Uchiyama H et al. (1999) Alterations ofmuscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer’s disease. J Neurol Neurosurg Psychiatry 67: 209–213PubMedCrossRef
25.
Zurück zum Zitat Shulman KI (2000) Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548–561PubMedCrossRef Shulman KI (2000) Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548–561PubMedCrossRef
26.
Zurück zum Zitat Simard M, Reekum R van (2004) The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci Fall 16: 409–425 Simard M, Reekum R van (2004) The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci Fall 16: 409–425
27.
Zurück zum Zitat Wesnes KA, McKeith IG, Ferrara R et al. (2002) Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 13: 183–192PubMedCrossRef Wesnes KA, McKeith IG, Ferrara R et al. (2002) Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 13: 183–192PubMedCrossRef
28.
Zurück zum Zitat Zaccai J, McCracken C, Brayne C (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34: 561–566PubMedCrossRef Zaccai J, McCracken C, Brayne C (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34: 561–566PubMedCrossRef
Metadaten
Titel
Demenz mit Lewy-Körperchen
Besserung unter Therapie mit einem Acetylcholinesteraseinhibitor
verfasst von
M. Omerovic
S.J. Teipel
T. Hampel
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Der Nervenarzt / Ausgabe 9/2007
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-007-2277-1

Weitere Artikel der Ausgabe 9/2007

Der Nervenarzt 9/2007 Zur Ausgabe

Übersichten

Verhaltenssucht

Neu in den Fachgebieten Neurologie und Psychiatrie